Parasite in My Head: a Case of an Infectious Lesion Presenting as a Metastatic Tumor in an Adult with HIV infection

Jemma Ma. Irene  V. Echiverri,

Parasite in My Head: a Case of an Infectious Lesion Presenting as a Metastatic Tumor in an Adult with HIV infection

Abstract:

Introduction: Toxoplasmic encephalitis among HIV-infected individuals is usually a complication of the late phase of immunodeficiency. In the Philippines, only 3 cases of cerebral toxoplasmosis were reported among 522 HIV-infected individuals. Case: This is a case of a 32-year-old male who came in due to rotatory dizziness and headache with increasing severity of dizziness affecting his daily performance. With a differential diagnosis of metastatic tumor versus infectious lesion, further diagnostic examinations were done to evaluate the case. Discussion/Conclusion: This report shows the significance of this rare case among HIV patients. A space- occupying lesion in an HIV-positive individual can present like a metastatic tumor. Among adults and adolescents with headache and focal neurologic symptoms, HIV testing may be an important screening tool together with history taking. Seropositive individuals are suggested to be further worked up and screened with toxoplasma titer.

References:

HIV/AIDS and ART Registry of the Philippines – DoH [Internet] March 2016. Available from https://www.doh.gov.ph/sites/default/files/.../EB_HIV_June-AIDSreg2016_0.pdf
Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211-22.
Ho YC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical Presentation and Outcome of Toxoplasmic Encephalitis in Patients with Human Immunodeficiency Virus Type 1 Infection. J Microbiol Immunol. 2008;41:386-392
Antinori A, Larussa D, Cingolani A, Lorenzini P, Bos- solasco S, Finazzi MG, et al.,; Italian Registry Investigative NeuroAIDS. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1681-91.
Sacktor N, Lyles RH, Skolasky R, et al; Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 2001;56:257–60.
Abgrall S, Rabaud C, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001;33:1747–55.
Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992;15:211–22.
San-Andres FJ, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immune deficiency virus, 1989–1997. Clin Infect Dis 2003;36:1177–85.
Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607–25.
Rabaud C, May T, Amiel C, et al. Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey. Medicine (Baltimore) 1994; 73:306–14.
Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: Saunders; 2001:205–346.
Ferguson DJP. Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore. Memorias do Instituto Oswaldo Cruz 104(2):133-48. doi: 10.1590/ S0074-02762009000200003.
Magnerou et al., Clinical, brain imaging and therapeutic evaluation of toxoplasma encephalitis in HIV-infected patients in Yaounde. Retrovirology 2012 9(Suppl 1):P145.
Maggi P, de Mari M, De Blasi R, Armenise S, Romanelli C, Andreula C, Zimatore G, Angarano G. Choreoathetosis in Acquired Immune Deficiency Syndrome Patients with Cerebral Toxoplasmosis. Movement Disorders 1996 Jul;11(4):434-6.
Alfonso Y et. al., Molecular Diagnosis of Toxoplasma Gondii Infection in Cerebrospinal Fluid from AIDS Patients. Cerebrospinal Fluid Res. 2009 6:2
Solante R, Chua M, et. Al. Clinical Practice Guidelines on the Prevention, Diagnosis and Treatment of Opportunistic Infections in Human Immunodeficency Virus-Infected adults and adolescents in the Philippines.HIV Working Group - Philippine Society for Microbiology and Infectious Diseases , 2016
Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475–95.
Marra CM. CNS opportunistic infection in HIV [Internet]. Location: Northwest AIDS Education and Training Center; Jul 2016 [cited 2018] Available from https://depts.washington.edu/nwaetc/presentations/uploads/59/hiv_and_cns_opportunisticinfections_in_hiv.pdf
San-Andres FJ, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodefi ciency virus, 1989–1997. Clin Infect Dis 2003;36:1177–85.
Portegies P et. al. Guidelines for the Diagnosis and Management of Neurological Complications of HIV Infection. EFNS Eur J Neurol. 2004, 11:297-304.
Mofenson LM, Brady MT, Dabber SP, Doninguez KL, Hazra R, Handelsman E, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV- Exposed and HIV-Infected Children: Recommendations from CDC, the NIH, the HIV Medicine Association of Infections Disease Society of America, the Pediatric Infectious Disease Society and the American Academy of Pediatrics. MMWR Recomm Rep. 2009 Sept.4; 58(RR-11):1.
Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous systemtoxoplasmosis in AIDS. AIDS. 1990 Jun;4(6):519-21.
Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986 Mar;19(3):224-38.
Conley FK, Jenkins KA, Remington JS. Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections. Hum Pathol. 1981 Aug;12(8):690-8.
Farkash AE, Maccabee PJ, Sher JH, Landesman SH, Hotson G. CNS toxoplasmosis in acquired immune deficiency syndrome: a clinical-pathological-radiological review of 12 cases. J Neurol Neurosurg Psychiatry. 1986 Jul;49(7):744-8.
Wong KH, Chan KCW, Lee SS, editors. HIV manual 2001. Hong Kong: Integrated Treatment Centre Special Preventive Programs, DOH. Red Ribbon Centre; 2002 Jan.193-8p.
Torre D, Casari S, Speranza F, Donisi A, et. al., Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS. Antimicrob Agents Chemother 1998, 1346–1349.
Duval X, Pajot O, Le Moing V, et al., Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy. AIDS 2004; 18: 1342--4.
Podzamczer D, Miro JM, Ferrer E, et al., Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 2000;19:89--95.
Bobic B, Nikolic A, Klun I, Vujanic M, Djurkovic- Djakovic O. Undercooked Meat Consumption Remains the Major Risk Factor for Toxoplasma Infection in Serbia. Parassitologia 2007 Dec;49(4):227-230.
Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk Factors for Toxoplasma Gondii Infection in the United States. Clin Infect Dis. 2009 Sep 15; 49 (6):878-84.
Ribera E, Fernandez-Sola A, Juste C, Rovira A, Romero F, Armadans-Gil L, Ruiz I, Ocana I, Pahissa A. Comparison of High and Low doses of Trimethoprim- Sulfamethoxazole for Primary Prevention of Toxoplasmic Encephalitis in Human Immunodeficiency Virus-infected Patients. Clin Infect Dis. 1999; 29:1461-6.